Clinical trials
Phase 3 Endocrine System Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Visen Pharmaceuticals (Shanghai) Co., Ltd. | 2 |
| AstraZeneca | 1 |
| Daewoong Pharmaceutical Co. LTD. | 1 |
| Sumitomo Pharma America, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocrine System Diseases | 7 |
| Diabetes Mellitus, Type 2 | 4 |
| Diabetes Mellitus | 3 |
| Glucose Metabolism Disorders | 3 |
| Metabolic Diseases | 3 |
| Adenocarcinoma | 1 |
| Carcinoma, Pancreatic Ductal | 1 |
| Digestive System Diseases | 1 |
| Digestive System Neoplasms | 1 |
| Dwarfism, Pituitary | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.